Statins attenuate polymethylmethacrylate-mediated monocyte activation.
AffiliationDepartment of Surgical Research, Cork University Hospital, Cork, Ireland., email@example.com
Arthroplasty, Replacement/adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology
MetadataShow full item record
CitationActa Orthop. 2008 Feb;79(1):134-40.
AbstractBACKGROUND: Periprosthetic osteolysis precipitates aseptic loosening of components, increases the risk of periprosthetic fracture and, through massive bone loss, complicates revision surgery and ultimately is the primary cause for failure of joint arthroplasty. The anti-inflammatory properties of HMG-CoA reductase inhibitors belonging to the statin family are well recognized. We investigated a possible role for status in initiating the first stage of the osteolytic cycle, namely monocytic activation. METHODS: We used an in vitro model of the human monocyte/macrophage inflammatory response to poly-methylmethacrylate (PMMA) particles after pretreat-ing cells with cerivastatin, a potent member of the statin family. Cell activation based upon production of TNF-alpha and MCP-1 cytokines was analyzed and the intracellular Raf-MEK-ERK signal transduction pathway was evaluated using western blot analysis, to identify its role in cell activation and in any cerivastatin effects observed. RESULTS: We found that pretreatment with cerivastatin significantly abrogates the production of inflammatory cytokines TNF-alpha and MCP-1 by human monocytes in response to polymethylmethacrylate particle activation. This inflammatory activation and attenuation appear to be mediated through the intracellular Raf-MEK-ERK pathway. INTERPRETATION: We propose that by intervening at the upstream activation stage, subsequent osteoclast activation and osteolysis can be suppressed. We believe that the anti-inflammatory properties of statins may potentially play a prophylactic role in the setting of aseptic loosening, and in so doing increase implant longevity.
- Polymethylmethacrylate and titanium alloy particles activate peripheral monocytes during periprosthetic inflammation and osteolysis.
- Authors: Yang SY, Zhang K, Bai L, Song Z, Yu H, McQueen DA, Wooley PH
- Issue date: 2011 May
- Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis.
- Authors: Koulouvaris P, Ly K, Ivashkiv LB, Bostrom MP, Nestor BJ, Sculco TP, Purdue PE
- Issue date: 2008 Jan
- Pitavastatin attenuates monocyte activation in response to orthopedic implant-derived wear particles by suppressing the NF-κB signaling pathway.
- Authors: Zhang Z, Dai F, Cheng P, Luo F, Hou T, Zhou Q, Xie Z, Deng M, Xu JZ
- Issue date: 2015 Nov
- Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?
- Authors: Liu YP, Yu GR, Li K, Yuan F
- Issue date: 2011 Feb
- The biology of aseptic osteolysis.
- Authors: Holt G, Murnaghan C, Reilly J, Meek RM
- Issue date: 2007 Jul